OncLive.com(@OncLive) 's Twitter Profile Photo

Health Canada has approved the use of the subcutaneous formulation of atezolizumab for the treatment of patients with lung cancer, breast cancer, or HCC where the intravenous formulation has been previously approved. onclive.com/view/health-ca…

Health Canada has approved the use of the subcutaneous formulation of atezolizumab for the treatment of patients with lung cancer, breast cancer, or HCC where the intravenous formulation has been previously approved. #lcsm #bcsm #hcc #oncology onclive.com/view/health-ca…
account_circle
Dr.Clara Park, MD, FACS(@KClaraPark) 's Twitter Profile Photo

Fantastic review by Tari King MD on post-neoadj residual calcs with MRI resolution. Cant definitively rule out residual disease in suspicious calcs even with MRI resolution so removal of residual calcs necessary. Dana-Farber’s Breast Oncology Center Brigham and Women's Hospital

Fantastic review by @TariKingMD on post-neoadj residual calcs with MRI resolution. Cant definitively rule out residual disease in suspicious calcs even with MRI resolution so removal of residual calcs necessary. #GBCC2024 #BCSM @DFCI_BreastOnc  @BrighamWomens
account_circle
Stephanie Graff, MD, FACP, FASCO(@DrSGraff) 's Twitter Profile Photo

Getting excited for
Abstract titles are officially out 👀
conferences.asco.org/am/abstracts

And no surprise, for the reign of ADCs continues. At first glance, some anticipated results for Dato-DXd and T-DXd from Rebecca Shatsky, MD FabriceAndre and Sonia Pernas. 👏🏻

Getting excited for #ASCO24 
Abstract titles are officially out  👀
conferences.asco.org/am/abstracts

And no surprise, for #bcsm the reign of ADCs continues. At first glance, some anticipated results for Dato-DXd and T-DXd from @Dr_RShatsky @FAndreMD and @SoniaPernas. 👏🏻
account_circle